What lab workup is recommended for a female patient presenting with hirsutism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Workup for Female Hirsutism

Measure total testosterone (TT) and free testosterone (FT) using liquid chromatography-tandem mass spectrometry (LC-MS/MS) as your first-line tests, drawn in the morning on cycle days 3-6, as these have the highest diagnostic accuracy with sensitivities of 74% and 89% respectively. 1, 2

First-Line Androgen Testing

  • Total testosterone (TT) should be measured using LC-MS/MS methodology, which has a pooled sensitivity of 74% and specificity of 86% for detecting biochemical hyperandrogenism 1, 2

  • Free testosterone (FT) should be assessed by equilibrium dialysis, ammonium sulfate precipitation, or calculated using the free androgen index (FAI = total testosterone/SHBG ratio) when direct measurement is unavailable, with FT showing superior sensitivity of 89% and specificity of 83% 1, 2

  • Avoid direct immunoassay methods for FT due to poor accuracy at low serum concentrations 1

  • Blood samples must be drawn in the morning (around 8 am) due to diurnal variation in testosterone levels 1, 2

  • Timing should be on cycle days 3-6 for women with regular cycles 2

Second-Line Androgen Testing (If TT/FT Not Elevated)

  • Androstenedione (A4) should be measured if TT or FT are not elevated, with sensitivity of 75% and specificity of 71% 1, 2

  • DHEAS (dehydroepiandrosterone sulfate) should be measured to identify adrenal androgen production, with age-specific cutoffs: >3800 ng/mL for ages 20-29, >2700 ng/mL for ages 30-39 1, 2

  • Very high DHEAS levels (>600 μg/dL) indicate an adrenal source and raise concern for adrenocortical carcinoma, warranting immediate imaging 1

  • Note that A4 and DHEAS have poorer specificity than testosterone measurements 1

Essential Screening Tests to Rule Out Other Causes

  • Thyroid-stimulating hormone (TSH) must be checked to exclude thyroid disease, which can present with similar symptoms 3, 1, 2

  • Prolactin levels should be measured to exclude hyperprolactinemia (abnormal if >20 μg/L), as this can cause menstrual irregularity and hirsutism 3, 1, 2

  • LH and FSH should be measured between cycle days 3-6, with an LH/FSH ratio >2 suggesting polycystic ovary syndrome (PCOS) 2

  • Mid-luteal progesterone should be assessed to evaluate ovulation, with levels <6 nmol/L indicating anovulation 2

Metabolic Screening (Critical for PCOS Evaluation)

  • Fasting glucose followed by 2-hour oral glucose tolerance test with a 75-gram glucose load should be performed to screen for type 2 diabetes and insulin resistance, as women with PCOS have demonstrated increased risk 3, 2

  • Fasting lipid panel including total cholesterol, LDL cholesterol, HDL cholesterol, and triglyceride measurements should be obtained to assess cardiovascular risk 3, 2

  • Calculate body mass index and waist-hip ratio as part of metabolic assessment 3

Red Flags Requiring Urgent Evaluation

  • Very high testosterone levels (>2.5 nmol/L or >150 ng/dL) or rapidly developing symptoms over a few months should prompt immediate investigation for androgen-secreting tumors of the ovary or adrenal gland 2, 4

  • Look for signs of virilization including clitoromegaly, deepening voice, male-pattern baldness, or increased muscle mass, which suggest tumor 1, 4

  • Markedly elevated DHEAS warrants evaluation for adrenal pathology with imaging 1, 2

Additional Testing for Specific Clinical Scenarios

  • 17-hydroxyprogesterone should be measured if non-classic congenital adrenal hyperplasia is suspected, particularly in certain ethnic populations where prevalence is 1-10% 5

  • Pelvic ultrasound (transvaginal preferred) should be performed if hormonal tests suggest PCOS or to rule out ovarian pathology, looking for >10 peripheral cysts of 2-8 mm diameter with thickened ovarian stroma 2

  • Consider 24-hour urinary free cortisol or overnight dexamethasone suppression test if clinical features suggest Cushing's syndrome (buffalo hump, moon facies, hypertension, abdominal striae, easy bruising) 3

Critical Technical Considerations

  • LC-MS/MS methodology is strongly preferred over immunoassays for all androgen measurements due to superior specificity and accuracy, particularly at the low concentrations seen in women 1, 2

  • SHBG fluctuations can affect TT and FAI results, influenced by age, weight, and medications like oral contraceptives 1

  • The 2023 International PCOS Guidelines emphasize that LC-MS/MS has superior accuracy compared to direct immunoassays across all androgen measurements 2

Common Pitfalls to Avoid

  • Do not rely on testosterone measurements alone if clinical suspicion is high—proceed to second-line testing with A4 and DHEAS 1, 2

  • Do not use direct immunoassay methods for free testosterone, as they are inaccurate at low serum concentrations typical in women 1

  • Do not forget to time blood draws appropriately—morning collection on cycle days 3-6 for androgens, mid-luteal phase for progesterone 2

  • Do not overlook metabolic screening, as PCOS (the most common cause, accounting for 80-90% of hirsutism cases) carries significant cardiovascular and diabetes risk 3, 5

References

Guideline

Hyperandrogenism Diagnosis and Evaluation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Laboratory Workup for Hirsutism in Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hirsutism in Women.

American family physician, 2019

Research

Approach to the Patient: Hirsutism.

The Journal of clinical endocrinology and metabolism, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.